These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4479374)

  • 1. [Biochemical mechanisms of extrapyramidal-motoric effect of haloperidol in man].
    Eben E; Ackenheil M; Raese J; Rüther E
    Arzneimittelforschung; 1974 Aug; 24(8):1133-5. PubMed ID: 4479374
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol.
    Rüther E; Schilkrut R; Ackenheil M; Eben E; Hippius H
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):33-6. PubMed ID: 981320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment.
    Beckmann H; Waldmeier P; Lauber J; Gattaz WF
    J Neural Transm; 1983; 57(1-2):103-10. PubMed ID: 6194254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of clozapine on the excretion of 3-methoxy-4-hydroxy-phenylglycol, homovanillic acid and 5-hydroxy-indole acetic acid in urine and cerebrospinal fluid].
    Ackenheil M; Beckmann H; Hoffmann G; Markianos E; Nyström I; Raese J
    Arzneimittelforschung; 1974 Jul; 24(7):984-7. PubMed ID: 4408052
    [No Abstract]   [Full Text] [Related]  

  • 5. Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients.
    Gerlach J; Thorsen K; Fog R
    Psychopharmacologia; 1975; 40(4):341-50. PubMed ID: 1096218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man.
    Ackenheil M; Beckmann H; Greil W; Hoffmann G; Markianos E; Raese J
    Adv Biochem Psychopharmacol; 1974; 9(0):647-57. PubMed ID: 4836227
    [No Abstract]   [Full Text] [Related]  

  • 7. Haloperidol in overt ambulatory schizophrenics.
    Darling HF
    Dis Nerv Syst; 1973; 34(7):364-7. PubMed ID: 4782293
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopaminergic dsyfunction in Tourette syndrome.
    Singer HS; Butler IJ; Tune LE; Seifert WE; Coyle JT
    Ann Neurol; 1982 Oct; 12(4):361-6. PubMed ID: 6184010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of haloperidol.
    Man PL
    Dis Nerv Syst; 1973 Feb; 34(2):113-8. PubMed ID: 4267586
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypokinetic-rigid extrapyramidal side effects of neuroleptics: the relationship of the silent period in EMG and HVA and 5-HIAA in CSF.
    Yazici O; Hizal A; Eroğlu L; Baslo A; Yazici J
    J Neurol Neurosurg Psychiatry; 1986 Apr; 49(4):448-50. PubMed ID: 2422327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolism of peripheral catecholamines and indole amines in healthy persons. Clinico-biochemical correlates].
    Krzyzowski J; Lewicka-Wysocka H; Lukaszewska B; Marcjan K; Pacyna M; Pietruszewska I; Roguska E; Stencka K
    Pol Tyg Lek; 1981 Mar; 36(11):417-21. PubMed ID: 6167972
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuroleptic malignant syndrome with myoglobinuria].
    Yasukawa M; Hatakeyama Y; Yasukawa K; Chiba S; Suzuki T; Takami T
    Masui; 1983 Jul; 32(7):876-82. PubMed ID: 6632189
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Cramer H; Warter JM; Renaud B
    Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship between clinical and biochemical changes following neuroleptic treatment in schizophrenia.
    Cooper SJ; Leahey W; Liddle J; King DJ
    Schizophr Res; 1990; 3(4):261-7. PubMed ID: 1703780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid transmitter metabolites and atmospheric pressure.
    Nordin C; Eklundh T
    Biol Psychiatry; 1996 Oct; 40(7):682-4. PubMed ID: 8886306
    [No Abstract]   [Full Text] [Related]  

  • 16. Repertory grid and biochemical characterization of depression: a comparison of case reports.
    Yesavage JA; Slater P; Berger PA
    J Clin Psychiatry; 1979 May; 40(5):232-5. PubMed ID: 438147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuroleptic syndrome and central dopamine metabolites.
    Tollefson GD; Garvey MJ
    J Clin Psychopharmacol; 1984 Jun; 4(3):150-3. PubMed ID: 6203936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of clozapine response in schizophrenia.
    Pickar D; Owen RR; Litman RE; Hsiao JK; Su TP
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():129-32. PubMed ID: 7525541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

  • 20. The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment.
    Schildkraut JJ
    Psychopharmacol Bull; 1974 Jan; 10(1):5-25. PubMed ID: 4590871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.